TWD 120.0
(-2.44%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 314.87 Million TWD | -41.74% |
2022 | 540.47 Million TWD | 1522.31% |
2021 | 33.31 Million TWD | 133.45% |
2020 | -99.59 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 272.33 Million TWD | -13.51% |
2024 Q2 | 340.62 Million TWD | 25.08% |
2023 Q1 | 445.56 Million TWD | 21.56% |
2023 FY | 314.87 Million TWD | -41.74% |
2023 Q4 | 314.87 Million TWD | -18.67% |
2023 Q3 | 387.13 Million TWD | -15.84% |
2023 Q2 | 459.98 Million TWD | 3.24% |
2022 Q4 | 366.54 Million TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 219.194% |
Level Biotechnology Inc. | -453.9 Million TWD | 169.37% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 260.325% |
GlycoNex Incorporation | -148.56 Million TWD | 311.94% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | -681.982% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | -128.177% |
Visgeneer Inc. | 31.28 Million TWD | -906.499% |
Mycenax Biotech Inc. | 207 Million TWD | -52.106% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 334.539% |
Neith Corporation | -150.31 Million TWD | 309.481% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 471.475% |
Lin BioScience, Inc. | -3.21 Billion TWD | 109.784% |
Feng Chi Biotech Corp. | -19.81 Million TWD | 1689.224% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | -889.887% |
Lukas Biomedical Inc. | 50.75 Million TWD | -520.378% |
BiOptic Inc. | 12.59 Million TWD | -2400.58% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 133.341% |
Sagittarius Life Science Corp | -120.57 Million TWD | 361.154% |
TaiMed Biologics Inc. | 499.84 Million TWD | 37.006% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 589.534% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 146.264% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 49.34% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 646.105% |
Enimmune corporation | -314.15 Million TWD | 200.227% |
TaiRx, Inc. | -147.86 Million TWD | 312.941% |
CHO Pharma, Inc. | -203.79 Million TWD | 254.507% |
EirGenix Inc. | -4.58 Billion TWD | 106.863% |
Sunny Pharmtech Inc. | 120.87 Million TWD | -160.503% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 199.198% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 410.262% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 290.629% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 219.914% |
VBI | -25.31 Million TWD | 1343.771% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -929.737% |
RBC Bioscience Corporation | 422.18 Million TWD | 25.418% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 508.692% |
NaviFUS Corp. | -123.12 Million TWD | 355.726% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | -325.211% |
Sinew Pharma Inc. | -160.34 Million TWD | 296.372% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 230.17% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 193.331% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 176.307% |
AP Biosciences Inc | -196.52 Million TWD | 260.218% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 54.282% |
3D Global Biotech Inc. | -11.43 Million TWD | 2853.108% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 137.951% |
Intech Biopharm Corporation | 1.35 Billion TWD | 76.802% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 175.895% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 250.414% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 318.87% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 195.26% |
TCI GENE Inc. | -689.25 Million TWD | 145.683% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 364.737% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 124.051% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -1437.241% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 409.093% |
PharmaEngine, Inc. | -860.8 Million TWD | 136.579% |
Savior Lifetec Corporation | -812.54 Million TWD | 138.752% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 204.969% |
OBI Pharma, Inc. | -398.22 Million TWD | 179.069% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 186.168% |
Acepodia, Inc. | -6.02 Billion TWD | 105.23% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 109.256% |